Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 24.87% is 13% below its 5-year average of 28.73%, near the low end of its 5-year range (24.87%–30.56%).
As of the fiscal period ended Tuesday, March 31, 2026. 10.94% below its 12-month average of 27.92%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
24.87%
DEBT TO ASSETS RATIO AVG TTM
27.92%
DEBT TO ASSETS RATIO AVG 3Y
28.58%
DEBT TO ASSETS RATIO AVG 5Y
28.92%
DEBT TO ASSETS RATIO AVG 10Y
29.98%
DEBT TO ASSETS RATIO AVG 15Y
28.23%
DEBT TO ASSETS RATIO AVG 20Y
27.67%
CURRENT VS TTM AVG
-10.94%
CURRENT VS 3Y AVG
-13.00%
CURRENT VS 5Y AVG
-14.01%
CURRENT VS 10Y AVG
-17.07%
CURRENT VS 15Y AVG
-11.93%
CURRENT VS 20Y AVG
-10.12%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+8475.01%
vs the sector median at left
Boston Scientific Corporation
Market Cap
$69.46B
Debt to Assets Ratio
24.87%
TTM Avg
27.92%
3Y Avg
28.58%
5Y Avg
28.92%
Market Cap
$78.57B
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.00B
Debt to Assets Ratio
0.35%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.87B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$49.56B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $69.46B | 24.87% | 27.92% | 28.58% | 28.92% |
| Cigna Corporation (CI)vs › | $73.82B | 0.20% | N/A | N/A | N/A |
| Cencora, Inc. (COR)vs › | $60.57B | 0.14% | N/A | N/A | N/A |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.57B | 0.07% | N/A | N/A | N/A |
| Becton, Dickinson and Company (BDX)vs › | $60.00B | 0.35% | N/A | N/A | N/A |
| Elevance Health Inc. (ELV)vs › | $81.51B | 0.27% | N/A | N/A | N/A |
| Cardinal Health, Inc. (CAH)vs › | $53.87B | 0.18% | N/A | N/A | N/A |
| HCA Healthcare, Inc. (HCA)vs › | $87.16B | 0.83% | N/A | N/A | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $49.56B | 0.05% | N/A | N/A | N/A |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.10B | 0.32% | N/A | N/A | N/A |
Debt/Assets
24.9%
Debt/Equity
0.51
Current Ratio
1.62
Interest Coverage
11.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 24.87% |
| 2025-12-31 | 28.43% |
| 2025-09-30 | 28.21% |
| 2025-06-30 | 28.94% |
| 2025-03-31 | 29.17% |
| 2024-12-31 | 28.30% |
| 2024-09-30 | 29.57% |
| 2024-06-30 | 29.47% |
| 2024-03-31 | 30.00% |
| 2023-12-31 | 27.02% |
| 2023-09-30 | 27.32% |
| 2023-06-30 | 28.14% |
| 2023-03-31 | 28.47% |
| 2022-12-31 | 28.59% |
| 2022-09-30 | 27.96% |
| 2022-06-30 | 28.97% |
| 2022-03-31 | 29.94% |
| 2021-12-31 | 29.32% |
| 2021-09-30 | 29.67% |
| 2021-06-30 | 30.36% |
| 2021-03-31 | 30.56% |
| 2020-12-31 | 30.99% |
| 2020-09-30 | 30.25% |
| 2020-06-30 | 31.76% |
| 2020-03-31 | 35.19% |
| 2019-12-31 | 33.62% |
| 2019-09-30 | 40.64% |
| 2019-06-30 | 39.18% |
| 2019-03-31 | 38.70% |
| 2018-12-31 | 33.48% |
| 2018-09-30 | 32.38% |
| 2018-06-30 | 32.94% |
| 2018-03-31 | 29.84% |
| 2017-12-31 | 29.29% |
| 2017-09-30 | 30.49% |
| 2017-06-30 | 31.74% |
| 2017-03-31 | 30.73% |
| 2016-12-31 | 30.31% |
| 2016-09-30 | 30.65% |
| 2016-06-30 | 30.42% |
| 2016-03-31 | 32.04% |
| 2015-12-31 | 31.31% |
| 2015-09-30 | 32.17% |
| 2015-06-30 | 29.85% |
| 2015-03-31 | 25.91% |
| 2014-12-31 | 25.32% |
| 2014-09-30 | 25.43% |
| 2014-06-30 | 25.82% |
| 2014-03-31 | 26.01% |
| 2013-12-31 | 25.34% |
| 2013-09-30 | 25.12% |
| 2013-06-30 | 25.02% |
| 2013-03-31 | 25.38% |
| 2012-12-31 | 24.81% |
| 2012-09-30 | 25.27% |
| 2012-06-30 | 23.66% |
| 2012-03-31 | 20.10% |
| 2011-12-31 | 20.01% |
| 2011-09-30 | 19.83% |
| 2011-06-30 | 19.49% |
| 2011-03-31 | 22.34% |
| 2010-12-31 | 24.58% |
| 2010-09-30 | 26.85% |
| 2010-06-30 | 26.21% |
| 2010-03-31 | 25.91% |
| 2009-12-31 | 23.51% |
| 2009-09-30 | 22.99% |
| 2009-06-30 | 23.86% |
| 2009-03-31 | 23.93% |
| 2008-12-31 | 24.85% |
| 2008-09-30 | 23.47% |
| 2008-06-30 | 24.36% |
| 2008-03-31 | 24.94% |
| 2007-12-31 | 26.25% |
| 2007-09-30 | 26.03% |
| 2007-06-30 | 28.48% |
| 2007-03-31 | 28.66% |
| 2006-12-31 | 28.63% |
| 2006-09-30 | 28.93% |
| 2006-06-30 | 29.07% |
| 2006-03-31 | 29.00% |
| 2005-12-31 | 24.65% |
| 2005-09-30 | 31.13% |
| 2005-06-30 | 25.44% |
| 2005-03-31 | 19.76% |
| 2004-12-31 | 28.97% |
| 2004-09-30 | 31.27% |
| 2004-06-30 | 34.36% |
| 2004-03-31 | 28.66% |
| 2003-12-31 | 30.27% |
| 2003-09-30 | 31.52% |
| 2003-06-30 | 26.93% |
| 2003-03-31 | 27.12% |
| 2002-12-31 | 21.01% |
| 2002-09-30 | 25.97% |
| 2002-06-30 | 28.44% |
